Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene

World Journal of Gastroenterology

Volumn 14, Issue 38, 2008, Pages 5810-5815

  Huang, Wei ^a   Tian, Xiang Long ^a   Wu, Yun Lin ^a   Zhong, Jie ^a   Yu, Li Fen ^a   Hu, Sheng Ping ^a   Li, Biao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Baculovirus; Gastric cancer; Gene therapy; Normal epithelial cell specific 1 gene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BACULOVIRUS VECTOR; SERINE PROTEINASE; GREEN FLUORESCENT PROTEIN; KALLIKREIN; KLK10 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH CURVE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUDE MOUSE; STOMACH CANCER; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; WESTERN BLOTTING; ANIMAL; BACULOVIRUS; BAGG ALBINO MOUSE; CELL PROLIFERATION; DRUG SCREENING; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; REPORTER GENE; STOMACH TUMOR; TIME; TUMOR CELL LINE;

ANIMALS; BACULOVIRIDAE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; KALLIKREINS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; STOMACH NEOPLASMS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 63449115326     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5810     Document Type: Article

References (22)

1. Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol 2007; 46: 277-285
2. Vogiatzi P, Cassone M, Claudio PP. Personalizing gene therapy in gastric cancer. Drug News Perspect 2006; 19: 533-540
3. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006; 12: 192-198
4. Huang W, Zhong J, Wu LY, Yu LF, Tian XL, Zhang YF, Li B. Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer. Cancer Lett 2007; 251: 78-85
5. Khalighinejad N, Hariri H, Behnamfar O, Yousefi A, Momeni A. Adenoviral gene therapy in gastric cancer: a review. World J Gastroenterol 2008; 14: 180-184
6. Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996; 93: 2348-2352
7. Matilainen H, Rinne J, Gilbert L, Marjomaki V, Reunanen H, Oker-Blom C. Baculovirus entry into human hepatoma cells. J Virol 2005; 79: 15452-15459
8. Jarvis DL, Garcia A Jr. Long-term stability of baculoviruses stored under various conditions. Biotechniques 1994; 16: 508-513
9. Heideman DA. Gene therapy and virotherapy of gastric cancer: preclinical results and clinical developments. Dig Dis 2004; 22: 374-379
10. Fumoto S, Nishi J, Nakamura J, Nishida K. Gene therapy for gastric diseases. Curr Gene Ther 2008; 8: 187-200
11. Condreay JP, Kost TA. Baculovirus expression vectors for insect and mammalian cells. Curr Drug Targets 2007; 8: 1126-1131
12. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92: 10099-10103
13. Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol 2002; 20: 173-180
14. Ghosh S, Parvez MK, Banerjee K, Sarin SK, Hasnain SE. Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther 2002; 6: 5-11
15. Luo L, Herbrick JA, Scherer SW, Beatty B, Squire J, Diamandis EP. Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem Biophys Res Commun 1998; 247: 580-586
16. Yousef GM, Luo LY, Diamandis EP. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res 1999; 19: 2843-2852
17. Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV. The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol Metab 2000; 11: 54-60
18. Zhang Y, Bhat I, Zeng M, Jayal G, Wazer DE, Band H, Band V. Human kallikrein 10, a predictive marker for breast cancer. Biol Chem 2006; 387: 715-721
19. Yunes MJ, Neuschatz AC, Bornstein LE, Naber SP, Band V, Wazer DE. Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery. Int J Radiat Oncol Biol Phys 2003; 56: 653-657
20. Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP, Wazer DE, Band V. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res 2001; 7: 3393-3383
21. Luo LY, Rajpert-De Meyts ER, Jung K, Diamandis EP. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br J Cancer 2001; 85: 220-224
22. Li B, Goyal J, Dhar S, Dimri G, Evron E, Sukumar S, Wazer DE, Band V. CpG methylation as a basis for breast tumor-specific loss of NES1/ kallikrein 10 expression. Cancer Res 2001; 61: 8014-8021